RecruitingNot ApplicableNCT06613204

STELLA-FTD: Examination of a Behavior Change Intervention for FTD Family Care Partners


Sponsor

Oregon Health and Science University

Enrollment

640 participants

Start Date

Jun 23, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this nationwide study is to test STELLA-FTD (Support via Telehealth: Living and Learning with Advancing Alzheimer's Disease)-FTD, an intervention to specifically address the needs of family Care Partners of persons with frontotemporal degeneration (FTD). STELLA-FTD is a multicomponent videoconference-based intervention designed to facilitate effective use of community and peer resources to foster effective management of behavioral and psychological symptoms of dementia. The study is recruiting families from across the United States.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called STELLA-FTD Control and a behavioral approach called STELLA-FTD Test for people with caregiver burden, corticobasal syndrome, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 100 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALSTELLA-FTD Control

Participants receive information about FTD and support via weekly group video-conference-based meetings.

BEHAVIORALSTELLA-FTD Test

The test group receives a information and support, but with a focus that is different from the Control Group


Locations(1)

Oregon Health & Science University

Portland, Oregon, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06613204


Related Trials